A Spot of Biotech Betting: Vera Therapeutics

The aforementioned Integral Health, in a filing that caused scarcely a ripple amongst the less observant, has increased its stake in Vera to a rather substantial 4.53% of its assets under management. A considerable sum, wouldn’t you agree? The total value of their holdings in the firm now stands at a respectable $91.15 million. One begins to suspect a degree of conviction, a notion that is rather refreshing in these days of fleeting fancies and speculative bubbles. They’ve clearly decided Vera isn’t just a passing phase.








